angiotensin ii has been researched along with orabase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coruh, A; Dagdelen, F; Soyuer, I | 1 |
| Abo-Salem, OM; El-Sayed, EM; Ismail, RS; Mohamed, BM; Saleh, IG | 1 |
2 other study(ies) available for angiotensin ii and orabase
| Article | Year |
|---|---|
Effect of topical angiotensin II on prelaminated flaps in rats and evaluation of angiogenesis with an immunohistochemical marker.
Topics: Administration, Topical; Angiogenesis Inducing Agents; Angiotensin II; Animals; Antigens; Carboxymethylcellulose Sodium; Factor VIII; Female; Immunohistochemistry; Neovascularization, Physiologic; Random Allocation; Rats; Rats, Sprague-Dawley; Staining and Labeling; Surgical Flaps | 2004 |
Olmesartan ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats via Nrf2/HO-1 signaling pathway.
Topics: Angiotensin II; Animals; Carboxymethylcellulose Sodium; Cyclooxygenase 2; Cyclophosphamide; Cystitis; Cytokines; Heme Oxygenase (Decyclizing); Imidazoles; Inflammation Mediators; Interleukin-6; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Tetrazoles; Tumor Necrosis Factor-alpha | 2022 |